Work

Milk Thistle Constituents Inhibit Raloxifene Intestinal Glucuronidation: A Potential Clinically Relevant Natural Product–Drug Interaction

Year: 2015

Type: article

Source: Drug Metabolism and Disposition

DOI: 10.1124/dmd.115.065086

Authors: Brandon T. Gufford, Gang Chen, Ana G. Vergara, Philip Lazarus, Nicholas H. Oberlies, Mary F. Paine

Institutions: University of North Carolina at Greensboro, Washington State University Spokane

Language: English

Topic: Pharmacogenetics and Drug Metabolism

Subfield: Pharmacology

Field: Pharmacology, Toxicology and Pharmaceutics

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: green

Funders: U.S. Food and Drug Administration, National Institute of General Medical Sciences, National Institute of Environmental Health Sciences

Awards: The UGT2A and 3A metabolizing enzymes and tobacco-related cancer risk, G4340343398, G5120621877

OpenAlex ID: W2136191240

FWCI: 3.936

Cites: 61

Cited by: 29

Related to: 10